Long-term administration of antiepileptic drugs and the development of rickets.
D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects*; D002118:Calcium / Q000097:blood / Q000627:therapeutic use; D003975:Diazepam / Q000009:adverse effects; D005013:Ethosuximide / Q000009:adverse effects; D005260:Female; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008618:Mephobarbital / Q000009:adverse effects; D010018:Osteomalacia / Q000139:chemically induced; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D010758:Phosphorus / Q000097:blood; D011324:Primidone / Q000009:adverse effects; D011859:Radiography; D012279:Rickets / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D012640:Seizures / Q000188:drug therapy; D013997:Time Factors; D014293:Trimethadione / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use
D000927:Anticonvulsants; D005942:Gluconates; D011324:Primidone; D014807:Vitamin D; D010758:Phosphorus; D008618:Mephobarbital; D005013:Ethosuximide; D010672:Phenytoin; D000469:Alkaline Phosphatase; D003975:Diazepam; D014293:Trimethadione; D002118:Calcium; D010634:Phenobarbital